BJDX

Bluejay Diagnostics, Inc.

Latest Form 4:Purchase$97KbyHRT FINANCIAL LP (10% Owner) · filed Jul 13, 2026

Bluejay Diagnostics, Inc. (BJDX) has 7 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 18, 2026.

Insiders have net bought $173K over the trailing 6 months.

  • Industry:Medical - Devices
  • CEO:Indranil Dey
  • Employees:6
  • HQ:Acton, MA, US
  • IPO:2021-11-10

Insider Buying

$222K

reported purchases (SEC code P)

Insider Selling

$49K

reported sales (SEC code S)

Unique Insiders

6

in the rolling window

Market Cap

$4.0M

latest known value

Source
Purchase$97KJul 13SEC ↗
Sale$49KJul 13SEC ↗
Dey IndranilFirst filing
Purchase$25KMay 18SEC ↗
CHASE DONALD RFirst filing
Purchase$25KMay 18SEC ↗
Purchase$25KMay 18SEC ↗
Dey SvetlanaFirst filing
Purchase$25KMay 18SEC ↗
ZEIDMAN FRED SFirst filing
Purchase$25KMay 18SEC ↗

Related companies

Bluejay Diagnostics, Inc. is in the Healthcare sector.